Expired contract
Supply of Remdesivir
Details
- Supplier(s)
- Gilead Sciences Ltd, 280 High Holborn
- Value
- GBP 5,739,200
- Duration
- 4 months
- Topic
- Pharmaceutical products
- Published
- 7 October 2022
- Source
- uk:contracts_finder
Tender description
This contract is call off no. 10 from a EU Framework Agreement for the Supply of Remdesivir.
Timeline
- Completed: Award date28 February 2022
- Completed: Contract expiry date7 July 2022
- Completed: Award published7 October 2022Current notice
About the buyer
Department of Health and Social Care is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov |
6 similar open tenders
See more open tenders related to Supply of Remdesivir.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to Department of Health and Social Care.
BuyersCountValue
- 1,716£205.5bn
- 1,538£58.4bn
- 751£1.3bn
- 692£133.2bn
- 641£160.0bn
- 463£8.5bn
- 338£7.4bn
- 327£1.3bn
- 281£1.1bn
- 228£550.1m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
